UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 31.104
NA - Nord America 19.430
EU - Europa 6.674
SA - Sud America 1.847
OC - Oceania 208
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 18
Totale 59.405
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 23.092
US - Stati Uniti d'America 19.095
SG - Singapore 3.624
CN - Cina 2.112
BR - Brasile 1.537
IT - Italia 1.458
UA - Ucraina 1.421
VN - Vietnam 929
RU - Federazione Russa 923
DE - Germania 777
IE - Irlanda 633
KR - Corea 450
TR - Turchia 402
SE - Svezia 349
FI - Finlandia 314
GB - Regno Unito 246
CA - Canada 198
EE - Estonia 146
IN - India 132
AR - Argentina 124
NZ - Nuova Zelanda 104
AU - Australia 98
MX - Messico 77
PL - Polonia 65
NL - Olanda 59
EC - Ecuador 57
BD - Bangladesh 56
AT - Austria 53
FR - Francia 51
JP - Giappone 51
ID - Indonesia 44
ES - Italia 41
IQ - Iraq 39
CO - Colombia 30
CZ - Repubblica Ceca 30
ZA - Sudafrica 30
PK - Pakistan 26
MA - Marocco 23
PY - Paraguay 23
UZ - Uzbekistan 22
VE - Venezuela 22
CL - Cile 21
IL - Israele 20
EU - Europa 16
AE - Emirati Arabi Uniti 15
DO - Repubblica Dominicana 14
PE - Perù 14
LT - Lituania 13
BE - Belgio 11
UY - Uruguay 11
EG - Egitto 10
AZ - Azerbaigian 9
BG - Bulgaria 9
KE - Kenya 9
AL - Albania 8
JM - Giamaica 8
SA - Arabia Saudita 8
DK - Danimarca 7
ET - Etiopia 7
IR - Iran 7
NP - Nepal 7
TN - Tunisia 7
BO - Bolivia 6
CH - Svizzera 6
CR - Costa Rica 6
DZ - Algeria 6
JO - Giordania 6
BA - Bosnia-Erzegovina 5
BW - Botswana 5
GR - Grecia 5
PH - Filippine 5
RO - Romania 5
SV - El Salvador 5
TW - Taiwan 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
KZ - Kazakistan 4
LU - Lussemburgo 4
ME - Montenegro 4
OM - Oman 4
PA - Panama 4
PR - Porto Rico 4
PT - Portogallo 4
RS - Serbia 4
BH - Bahrain 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
MN - Mongolia 3
MY - Malesia 3
NI - Nicaragua 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SO - Somalia 3
TJ - Tagikistan 3
AO - Angola 2
BS - Bahamas 2
BZ - Belize 2
Totale 59.344
Salva come PNG Salva come JPEG
Città #
Hong Kong 23.073
Ann Arbor 4.156
Wilmington 2.250
Jacksonville 1.729
Princeton 1.634
Chandler 1.535
Singapore 1.460
Dallas 1.119
Houston 740
Ashburn 643
Woodbridge 616
Dublin 594
Dong Ket 459
Beijing 400
Nanjing 399
Andover 368
Izmir 364
Moscow 314
Boardman 298
Pellezzano 264
Düsseldorf 216
Mestre 203
Ho Chi Minh City 175
Los Angeles 173
Naples 149
Tallinn 146
Norwalk 143
São Paulo 137
Shenyang 134
Fairfield 131
Salerno 122
Hebei 121
Munich 121
Changsha 112
Nanchang 108
Dearborn 107
New York 102
Hanoi 90
Jiaxing 85
Rome 67
The Dalles 67
Redwood City 60
Tianjin 56
Nuremberg 54
Rio de Janeiro 53
Warsaw 52
Brooklyn 50
San Diego 49
Pune 48
Santa Clara 45
Montreal 44
Auckland 43
Columbus 42
Sydney 42
Tokyo 40
Stockholm 39
Milan 38
San Francisco 38
Council Bluffs 37
Seoul 37
Belo Horizonte 36
Turku 35
West Jordan 35
Amsterdam 34
Washington 33
Curitiba 32
Seattle 32
Cambridge 31
Atlanta 30
Boston 30
Brasília 30
Jinan 29
Phoenix 29
Casoria 28
London 27
Ottawa 27
Poplar 27
Chennai 24
Chicago 24
Denver 24
Porto Alegre 24
Guangzhou 23
Lappeenranta 23
Haiphong 22
Fort Worth 21
Guayaquil 21
Campinas 20
Toronto 20
Guarulhos 19
Springfield 19
Tashkent 19
Johannesburg 18
Quito 18
Shanghai 18
Venezia 18
Vienna 18
Ankara 17
Baghdad 17
Bologna 16
Melbourne 16
Totale 46.975
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.170
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 964
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 931
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 917
Trial of Deferiprone in Parkinson's Disease 657
Sex Differences in Parkinson’s Disease: From Bench to Bedside 630
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 585
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 577
Cognitive impairment in nondemented Parkinson's disease. 564
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 556
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 530
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 530
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 519
Gender differences in microRNA expression in levodopa-naive PD patients 518
A simulation tool to plan daily nurse requirements 508
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 503
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 492
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 481
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 457
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 440
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 438
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 430
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 430
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 414
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 413
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 411
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 392
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 376
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 375
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 363
Neurotransmission in Parkinson's disease: beyond dopamine. 355
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 336
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 333
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 312
Bilateral facial palsy after COVID-19 vaccination 310
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 308
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 302
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 299
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 294
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial 293
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 291
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 285
A novel phenotype in an Italian family with a rare progranulin mutation 277
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 277
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 264
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 264
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 260
Trial of Cinpanemab in Early Parkinson's Disease 249
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 249
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 246
Classifying Different Stages of Parkinson’s Disease Through Random Forests 240
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 236
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 230
Metabolomics in Parkinson's disease 227
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 215
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 203
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 199
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 196
Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates 195
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 189
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 186
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 179
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 173
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 170
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 167
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 167
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 166
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 165
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 160
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 156
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 151
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 149
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 148
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 148
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 147
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 146
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 142
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 140
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 140
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 140
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 138
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 137
Affective theory of mind in patients with Parkinson's disease: comment 136
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 132
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 131
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 131
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 129
Increased bilirubin levels in de novo Parkinson's disease 127
The natural history of multiple system atrophy: A prospective European cohort study 126
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 126
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 125
Normative data for the Montreal Cognitive Assessment in an Italian population sample 125
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 125
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 124
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 123
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. 122
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 121
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 121
Quitting smoking: An early non-motor feature of Parkinson's disease? 120
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 120
Totale 30.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.093 0 0 0 0 363 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202629.448 4.870 11.165 9.973 1.342 2.098 0 0 0 0 0 0 0
Totale 60.483